Genufood Energy Enzymes Corp
OTC:GFOO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Genufood Energy Enzymes Corp
OTC:GFOO
|
US |
|
A
|
Autocorp Holding PCL
SET:ACG
|
TH |
|
HUTCHMED (China) Ltd
LSE:HCM
|
HK |
|
Bank of Hawaii Corp
NYSE:BOH
|
US |
|
Elior Group SA
PAR:ELIOR
|
FR |
|
Fast Finance 24 Holding AG
XETRA:FF24
|
DE |
|
Novozymes A/S
OTC:NVZMY
|
DK |
|
P
|
Phihong Technology Co Ltd
TWSE:2457
|
TW |
|
Synovus Financial Corp
NYSE:SNV
|
US |
|
K
|
Kingspan Group PLC
ISEQ:KRX
|
IE |
Balance Sheet
Balance Sheet Decomposition
Genufood Energy Enzymes Corp
Genufood Energy Enzymes Corp
Balance Sheet
Genufood Energy Enzymes Corp
| Sep-2010 | Sep-2011 | Sep-2012 | Sep-2013 | Sep-2018 | Sep-2019 | Sep-2020 | Sep-2021 | Sep-2022 | Sep-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash |
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
1
+1 100%
|
1
+124%
|
1
-11%
|
0
-86%
|
0
-28%
|
0
-85%
|
0
+2 027%
|
0
-61%
|
0
+34%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
-74%
|
0
+76%
|
0
+79%
|
0
+10%
|
0
+28%
|
0
+5%
|
0
-65%
|
0
+78%
|
0
-37%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
7
|
7
|
0
|
0
|
0
|
1
|
|
| Retained Earnings |
0
|
1
|
1
|
3
|
8
|
8
|
8
|
10
|
10
|
11
|
|
| Additional Paid In Capital |
0
|
1
|
4
|
4
|
5
|
5
|
15
|
17
|
17
|
17
|
|
| Other Equity |
0
|
0
|
2
|
1
|
5
|
5
|
7
|
7
|
7
|
7
|
|
| Total Equity |
0
N/A
|
1
N/A
|
1
+131%
|
1
-21%
|
0
N/A
|
0
-112%
|
0
-52%
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Total Liabilities & Equity |
0
N/A
|
1
+1 100%
|
1
+124%
|
1
-11%
|
0
-86%
|
0
-28%
|
0
-85%
|
0
+2 027%
|
0
-61%
|
0
+34%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
208
|
383
|
4
|
4
|
69
|
91
|
104
|
300
|
300
|
809
|
|